From this webinar you will learn:
• Insights derived from data to showcase the impact of COVID-19 on ongoing clinical trials by phase, recruitment status, sponsors and therapeutic area.
• Our interpretation and recommendations on the recent regulatory guidance’s for Sponsors and CROs
• The statistical considerations for protocol amendments in the areas recommended by regulatory authorities using a case study.

Register now: